Reports for TEVA CANADA LIMITED

Formerly known as ACTAVIS PHARMA COMPANY

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

214 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

2706 (92%)

2930

Discontinuation Reports

To be discontinued:

2 (1%)

Discontinued:

298 (99%)

Reversed:

0 (0%)

300

363 (11%)

103 (48%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-OMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2023-06-08 2023-08-18 194116
TEVA-OMEPRAZOLE 10MG TABLET (DELAYED-RELEASE) Resolved 2018-03-13 2018-05-30 42607
TEVA-OMEPRAZOLE 10MG TABLET (DELAYED-RELEASE) Resolved 2024-01-25 2024-03-14 217229
TEVA-OMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Actual shortage 2024-09-12 2025-05-02 237473
TEVA-OMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2020-08-27 2020-11-26 123090
TEVA-OMEPRAZOLE 10MG TABLET (DELAYED-RELEASE) Resolved 2024-01-25 2024-06-20 217231
TEVA-OMEPRAZOLE 10MG TABLET (DELAYED-RELEASE) Resolved 2019-12-12 2020-08-28 101142
TEVA-OMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2020-08-13 2020-12-03 122214
TEVA-OMEPRAZOLE 10MG TABLET (DELAYED-RELEASE) Actual shortage 2025-05-02 2025-05-02 256456
TEVA-OMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2023-06-16 2023-07-05 195177
TEVA-OMEPRAZOLE 10MG TABLET (DELAYED-RELEASE) Resolved 2020-09-24 2020-12-17 125013
TEVA-ONDANSETRON 4MG TABLET Actual shortage 2025-01-09 2025-01-09 247360
TEVA-OXYBUTYNIN 5MG TABLET Resolved 2017-10-02 2019-02-01 24103
TEVA-OXYBUTYNIN 5MG TABLET Resolved 2017-10-02 2019-02-01 24106
TEVA-OXYCOCET 325MG 5MG TABLET Resolved 2023-07-05 2023-07-21 197507
TEVA-OXYCOCET 325MG 5MG TABLET Resolved 2019-07-02 2019-08-10 88213
TEVA-OXYCOCET 325MG 5MG TABLET Resolved 2019-12-12 2020-03-12 101148
TEVA-OXYCOCET 325MG 5MG TABLET Resolved 2022-04-28 2022-07-20 159578
TEVA-OXYCOCET 325MG 5MG TABLET Resolved 2024-04-11 2024-05-03 224883
TEVA-OXYCOCET 325MG 5MG TABLET Resolved 2023-08-03 2023-08-18 200873
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-04-25 2025-04-25 255818
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623